Literature DB >> 1805542

X-ray microanalysis of fluoride distribution in microfracture calluses in cancellous iliac bone from osteoporotic patients treated with fluoride and untreated.

G Boivin1, B Grousson, P J Meunier.   

Abstract

Fluoride is able to augment cancellous bone mass in vertebral osteoporosis but is responsible for osteoarticular side effects in which microfractures are thought to be involved. During healing of these microfractures, a callus is formed all around the cancellous fracture line. Our hypothesis is that in fluoride-treated osteoporotic patients, calluses are bone sites where fluoride is focally deposited at a high concentration, and this could induce a local defect of calcification with a poor healing of microfractures. Our aim was to validate this hypothesis on several calluses following microfractures in undecalcified iliac cancellous bone from six women with osteoporosis (four fluoride treated and two untreated). Histologically normal iliac cancellous bone tissue, taken from a subject having neither fluoride treatment nor microfracture, was also examined. Selected areas, including new woven bone (calluses) and old lamellar bone, were carbon-coated and analyzed using an electron microprobe. Fluoride K alpha and calcium K alpha radiations were detected with wavelength and energy-dispersive spectrometers, respectively. In old lamellar bone at a distance from microfractures, the fluoride level was similar in normal and untreated osteoporotic patients but was slightly increased in treated osteoporotic patients. In untreated osteoporotic patients, the fluoride level was slightly higher (about 1.2 times) at the site of microfractures (lamellar and woven bone) than in lamellar bone far from such fractures, but fluoride was homogeneously distributed in lamellar and woven bone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805542     DOI: 10.1002/jbmr.5650061107

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

1.  Bone strength: the bottom line.

Authors:  T A Einhorn
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

2.  What is the future for fluoride in the treatment of osteoporosis?

Authors:  J D Ringe; P J Meunier
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

3.  Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study.

Authors:  J L Sebert; P Richard; I Mennecier; J P Bisset; G Loeb
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

4.  Relationship between bone fluoride content and histological evidence of calcification defects in osteoporotic women treated long term with sodium fluoride.

Authors:  G Boivin; J Duriez; M C Chapuy; B Flautre; P Hardouin; P J Meunier
Journal:  Osteoporos Int       Date:  1993-07       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.